Mesoblast Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Mesoblast Contact Number

Contact Us Mesoblast Ltd

Just Now Mesoblast.com Get All

844 889 6376

Mesoblast Inc. 505 Fifth Avenue Level 3 New York, NY 10017. Mesoblast Limited. 55 Collins Street Level 38 Melbourne 3000. Mesoblast. 21 Biopolis Road #01-22 Nucleos (South Tower) Singapore 138567. TFN: 1 844 889 MESO TFN: 1 844 889 6376 T: +1 212 880 2060 F: +1 212 880 2061 E: [email protected] TFN: 1 800 89 MESO TFN: 1 800 89 6376 T: +61 3

Website: https://mesoblast.com/company/contact-us

Category: Contact SupportShow more

Home Mesoblast Ltd

2 hours ago Mesoblast.com Get All

Mesoblast COVID-19 ARDS Trial Topline 60-Day Results. February 11, 2021 Mesoblast Phase 3 Chronic Low Back Pain Results. December 18, 2020 Mesoblast Update on COVID-19 ARDS Trial. December 15, 2020 Mesoblast Phase 3 Chronic Heart Failure Results

Website: https://mesoblast.com/

Category: Home PhoneShow more

Mesoblast Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com Get All

(212) 880-2060

Company Type For Profit. Number of Exits 1. Contact Email [email protected]mesoblast.com. Phone Number (212) 880-2060. Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including

Founded: 2004
Founder: Silviu Itescu

Website: https://www.crunchbase.com/organization/mesoblast

Category: Contact NumberShow more

Mesoblast Overview, News & Competitors ZoomInfo.com

3 hours ago Zoominfo.com Get All

Mesoblast’s headquarters are in 55 Collins Street Level 38, Melbourne, Victoria, 3000, Australia What is Mesoblast’s phone number? Mesoblast’s phone number is +61 3 9639 6036

Website: https://www.zoominfo.com/c/mesoblast-limited/72746556

Category: Contact NumberShow more

MESOBLAST LIMITED Company Profile Melbourne, …

1 hours ago Dnb.com Get All

MESOBLAST LIMITED is located in Melbourne, VICTORIA, Australia and is part of the {{industry}} Industry. MESOBLAST LIMITED has 102 total employees across all of its locations and generates $32.16 million in sales (USD). There are 7 companies in the MESOBLAST LIMITED corporate family.

Website: https://www.dnb.com/business-directory/company-profiles.mesoblast_limited.b9f0cee01071bda4dfc564a22174cee5.html

Category: Contact NumberShow more

SEC Filing Mesoblast

1 hours ago Investorsmedia.mesoblast.com Get All

855 881 1339

To access the call only, dial 1 855 881 1339 (U.S.), 1 800 558 698 (toll-free Australia) or +61 2 9007 3187 (outside of the U.S. and Australia). The conference identification code is 10000574. The archived webcast will be available on the Investor page of the Company’s website: www.mesoblast.com.

Website: http://investorsmedia.mesoblast.com/node/11436/html

Category: Contact NumberShow more

Mesoblast Email Format mesoblast.com Emails

2 hours ago Rocketreach.co Get All

Mesoblast uses 2 email formats: 1. first '.' [email protected]mesoblast.com (99.0%). Enter a name to find & verify an email >>> we have a process in place the begins with RocketReach and ends with huge contact lists for our sales team..it probably saves Feedtrail about 3 months of work in terms of lead gathering. We can divert our attention to actually

Website: https://rocketreach.co/mesoblast-email-format_b5cc4058f42e0ab1

Category: Contact NumberShow more

Mesoblast Company Profile Office Locations, …

6 hours ago Craft.co Get All

Mesoblast has 3.93k Twitter Followers. The number of followers has decreased 0.5% quarter over quarter

Website: https://craft.co/mesoblast

Category: Contact NumberShow more

ADR Trading FAQs Mesoblast

2 hours ago Investorsmedia.mesoblast.com Get All

For the most current Mesoblast ADR dividend information please visit www.adr.com or or you can call J.P. Morgan. Please have your account number, exact …

Website: https://investorsmedia.mesoblast.com/shareholder-services/investor-faqs/

Category: Contact NumberShow more

Mesoblast to set up stem cell drug plant in Singapore

2 hours ago Biospectrumasia.com Get All

Mesoblast to set up stem cell drug plant in Singapore. Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the company is in dialogues with Singapore Economic Development Board (EDB) for setting up a commercial site in Singapore.

Website: https://www.biospectrumasia.com/news/36/590/mesoblast-to-set-up-stem-cell-drug-plant-in-singapore.html

Category: Cell PhoneShow more

Mesoblast Limited ABN, ACN, Business names, Former names

8 hours ago Aubiz.net Get All

004-06-08

Mesoblast Limited is a limited by shares, listed public company, Australian public company. This corporation was registered on 2004-06-08 and was issued with the 109431870 ACN. Its Australian Business Number is 68109431870. Since 2004-07-01, the company is headquartered in VIC, post code 3000. Mesoblast Limited was registered for the GST on

Website: https://www.aubiz.net/company/mesoblast-limited-109431870/

Category: Contact NumberShow more

Grünenthal and Mesoblast Enter Strategic Partnership for

4 hours ago Globenewswire.com Get All

Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain. AACHEN, Germany

Website: https://www.globenewswire.com/news-release/2019/09/09/1913118/0/en/Gr%C3%BCnenthal-and-Mesoblast-Enter-Strategic-Partnership-for-Europe-and-Latin-America-to-Develop-and-Commercialise-Innovative-Cell-Therapy-for-the-Treatment-of-Chronic-Low-Back-Pain.html

Category: Contact NumberShow more

MESO Mesoblast Limited • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Get All

NEW YORK, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB))), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full-year ended June 30, 2021. The webcast will begin at 7.00pm EDT, Monday, August 30; 9.00am AEST, Tuesday, August 31, 2021.

Website: https://www.biopharmcatalyst.com/company/meso

Category: Contact NumberShow more

Mesoblast Share Price, Company News & Analysis Edison

1 hours ago Edisongroup.com Get All

Mesoblast is an Australia-headquartered biotechnology company focused on adult stem cell therapies. The company’s pipeline is based on its proprietary mesenchymal precursor cells (MPC) and culture-expanded mesenchymal stem cells (MSC) technologies. Novartis recently signed a partnership with the company to develop remestemcel-L for acute

Website: https://www.edisongroup.com/company/mesoblast/1619/

Category: Contact NumberShow more

MESOBLAST LIMITED : Shareholders Board Members Managers

7 hours ago Marketscreener.com Get All

Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.

Website: https://www.marketscreener.com/quote/stock/MESOBLAST-LIMITED-6499027/company/

Category: Contact NumberShow more

Elizabeth Burke Vice President Mesoblast ZoomInfo.com

3 hours ago Zoominfo.com Get All

View Elizabeth Burke's business profile as Vice President at Mesoblast. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Elizabeth-Burke/2018793845

Category: Contact NumberShow more

Mesoblast Limited (MESO) Company Profile & Facts Yahoo

4 hours ago Finance.yahoo.com Get All

See the company profile for Mesoblast Limited (MESO) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their

Website: https://finance.yahoo.com/quote/MESO/profile

Category: Contact NumberShow more

Mesoblast Limited: Rosen Law

2 hours ago Rosenlegal.com Get All

If you purchased Mesoblast securities between April 16, 2019 and October 1, please contact Phillip Kim, Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in …

Website: https://www.rosenlegal.com/cases-1923.html

Category: Contact NumberShow more

Mesoblast Wikipedia

9 hours ago En.wikipedia.org Get All

Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain . The company is led by Silviu Itescu, who founded the company in 2004.

Website: https://en.wikipedia.org/wiki/Mesoblast

Category: Contact NumberShow more

Mesoblast International Sàrl in Meyrin Moneyhouse

6 hours ago Moneyhouse.ch Get All

14.09.2011

Mesoblast International Sàrl is active in the industry «Leasing of intangible assets» and is currently active. The legal headquarters are in Meyrin. The company was founded on 14.09.2011. The last commercial register change was made on 04.03.2019. All changes can be viewed under the section « Notifications » and saved as a PDF.

Website: https://www.moneyhouse.ch/en/company/mesoblast-international-sarl-3091074481

Category: Contact NumberShow more

Investigation announced for Investors of Mesoblast Limited

4 hours ago Openpr.com Get All

Those who purchased shares of Mesoblast Limited (OTC: MEOBF) have certain options and should contact the Shareholders Foundation. Media Contact: Michael Daniels. Shareholders Foundation, Inc. 3111

Website: https://www.openpr.com/news/2238301/investigation-announced-for-investors-of-mesoblast-limited

Category: Contact NumberShow more

About Undiscovered Biotech

6 hours ago Undiscoveredbiotech.com Get All

January looms as a crucial month for the near-term prospects of Australian biotech, Mesoblast. December saw the company’s treatments fail to meet primary endpoints in both its Chronic Heart Failure (CHF) and COVID-19 Acute Respiratory Distress Syndrome (C19 ARDS) phase 3 trials. These failures, along with an earlier failure to be….

Website: https://www.undiscoveredbiotech.com/

Category: Tech SupportShow more

Mesoblast : Corporate Update Webcast MarketScreener

8 hours ago Marketscreener.com Get All

212 880 2060

For more information, please contact: Corporate Communications / Investors Schond Greenway Paul Hughes T: +1 212 880 2060 T: +61 3 9639 6036 E: [email protected]mesoblast.com. E: [email protected]mesoblast.com. Media Kristen Bothwell T: +1 917 613 5434

Website: https://www.marketscreener.com/quote/stock/MESOBLAST-LIMITED-6499027/news/Mesoblast-Corporate-Update-Webcast-32010310/

Category: Contact NumberShow more

Mesoblast Funding, Financials, Valuation & Investors

8 hours ago Crunchbase.com Get All

Mesoblast has raised a total of $337.3M in funding over 6 rounds. Their latest funding was raised on Mar 2, 2021 from a Post-IPO Equity round. Mesoblast is registered under the ticker ASX:MSB . Mesoblast is funded by 2 investors. Novaquest Capital Management and Australian Government for Research & Development are the most recent investors.

Website: https://www.crunchbase.com/organization/mesoblast/company_financials

Category: Contact NumberShow more

Mesoblast Limited: Culture LinkedIn

7 hours ago Linkedin.com Get All

Interview with Mesoblast Chairman Joseph R. Swedish. 2020 has been an unprecedented year due to the coronavirus pandemic, its impact on human health, and the economic consequences it has wrought.

Website: https://www.linkedin.com/company/mesoblast/life

Category: Contact NumberShow more

Mesoblast YouTube

3 hours ago Youtube.com Get All

David Oxley, SVP, Business Development and LicensingMelbourne, Australia(NASDAQ: MESO)Mesoblast Limited is a global leader in developing innovative cell-base

Website: https://www.youtube.com/watch?v=qUqjpmA1dFA

Category: Contact NumberShow more

MESOBLAST LTD (MEOBF) Company Profile & Facts Yahoo Finance

6 hours ago Finance.yahoo.com Get All

Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia. Corporate Governance Mesoblast Limited’s ISS Governance QualityScore as of July 1, 2021 is 9.

Website: https://finance.yahoo.com/quote/MEOBF/profile/

Category: Contact NumberShow more

Intermediatesize Expanded Access Program (EAP

7 hours ago Clinicaltrials.gov Get All

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04456439

Website: https://clinicaltrials.gov/ct2/show/NCT04456439

Category: Contact NumberShow more

Mesoblast Limited LinkedIn

2 hours ago Linkedin.com Get All

Mesoblast Limited 6,702 followers on LinkedIn. Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing

Website: https://www.linkedin.com/company/mesoblast

Category: Contact NumberShow more

Company Presentation Mesoblast Limited YouTube

3 hours ago Youtube.com Get All

MESOBLAST LIMITED :: Michael Schuster, Co-founder(ASX: MSB)Mesoblast is the world's largest regenerative medicine company and is in late-stage development of

Website: https://www.youtube.com/watch?v=4lo5ymrXj2g

Category: Contact NumberShow more

What Do Analysts Think Of Mesoblast Limited (MESO) – The

5 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 120.89 million. MESO does have institutional investors; and they hold 3.10% of the stock. Mesoblast Limited – Insider Activity and Holdings. Currently, the stock has been recommended as Moderate Buy …

Website: https://baxterreport.com/2021/09/02/what-do-analysts-think-of-mesoblast-limited-meso/

Category: Contact NumberShow more

Suman Abraham Associate Director, Research Mesoblast

9 hours ago Sg.linkedin.com Get All

Transcriptional profiling identified a number of novel… Thesis: Directed differentiation of human embryonic stem cells into haematopoietic and definitive endodermal lineages. Human Embryonic Stem Cells (hESCs) possess the potential to form, under the right experimental conditions, the roughly 220 cell types that comprise the human adult.

Title: Associate Director, Research at …
Location: Singapore, Singapore
Connections: 184

Website: https://sg.linkedin.com/in/suman-abraham-32761a55

Category: Contact NumberShow more

Why Mesoblast Stock Is Plunging After Q4 Earnings Report

5 hours ago Markets.businessinsider.com Get All

Why It Matters: Mesoblast posted revenue of $7.5 million, down 77% Y/Y. It posted a wider net loss of $98.8 million compared to $77.9 million. It posted a …

Website: https://markets.businessinsider.com/news/stocks/why-mesoblast-stock-is-plunging-after-q4-earnings-report-1030770696

Category: Contact NumberShow more

Mesoblast's Novartispartnered COVID19 cell therapy hits

9 hours ago Fiercebiotech.com Get All

Mesoblast has been put on blast by the FDA yet again after the agency requested another trial for its failed, Novartis-backed COVID-19 respiratory treatment. The …

Website: https://www.fiercebiotech.com/biotech/mesoblast-craters-again-as-fda-requests-another-trial-failed-covid-19-respiratory-treatment

Category: Cell PhoneShow more

COVID19 Treatment: Mesoblast partners with the CTSN to

5 hours ago Kalkinemedia.com Get All

Mesoblast Limited (ASX:MSB), Share price up by ~36% . Melbourne, Australia headquartered ASX listed healthcare sector company Mesoblast Limited is a leader in development of innovative cellular medicines at international level. Mesoblast has a robust emerging drug pipeline for follow-on signs with 3-programs currently in Phase 3 clinical studies.

Website: https://kalkinemedia.com/au/news/covid-19-treatment-mesoblast-partners-with-the-ctsn-to-conduct-human-trials-of-remestemcel-l

Category: Contact NumberShow more

Mesoblast Limited (NASDAQ:MESO) loss 4.93% – Is It right

9 hours ago Baxterreport.com Get All

Mesoblast Limited (MESO) saw downtrend of -4.93% in the recent trading with $6.75 being its most recent. The current price level -68.28% lower than the highest price of $21.28 marked by the stock while trading over the past 52-weeks, whereas it is -2.03% higher than the lowest price of $6.89 the company dropped to over past 52-weeks.

Website: https://baxterreport.com/2021/05/12/mesoblast-limited-nasdaqmeso-loss-4-93-is-it-right-time-to-buy/

Category: Contact NumberShow more

Mesoblast Ltd. (MEOBF) Stock Forecast & Price Predictions

1 hours ago Itradely.com Get All

According to the market data, Mesoblast Ltd. (MEOBF) stock price is $1.29 and the 52 weeks low is $0.01, which means the Mesoblast Ltd. stock price is down -65.60% in the last 12 months. Mesoblast Ltd. (MEOBF) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant

Website: https://itradely.com/stock-forecast/MEOBF

Category: Contact NumberShow more

Mesoblast Limited – Schall Law Firm

9 hours ago Schallfirm.com Get All

Mesoblast Limited. Join Class Action » According to the Complaint, the Company made false and misleading statements to the market. An analysis comparing Mesoblast’s Phase 3 trial with three historical trials did not demonstrate the effectiveness of remestemcel-L for steroid refractory acute graft versus host disease (“aGVHD”) because the four studies had different designs.

Website: https://schallfirm.com/cases/mesoblast-limited-2/

Category: Contact NumberShow more

Will Mesoblast recover from Teva & Celgene setbacks

Just Now Evolutionexec.com Get All

News of Teva’s decision to withdraw had an immediate impact, with Mesoblast shares hitting a 7-year low following a 42% dive post the 10-day trading halt. Teva’s decision to walk away is the second major setback revealed in recent months, following the failure of Celgene to exercise a six-month partnership option on Mesoblast’s research

Website: https://evolutionexec.com/news-analysis/will-mesoblast-recover-from-teva-celgene-setbacks/

Category: Contact NumberShow more

Mesoblast Limited: The Saga Continues Sick Economics

Just Now Sickeconomics.com Get All

MESOBLAST LIMITED: THE SAGA CONTINUES. It’s been a swashbuckling tale of biotech adventure. Management and investors in Mesoblast Limited have gone to hell and back in a bold quest to pioneer cell based inflammation therapies. Time and time again the company has announced exhilarating breakthroughs, only to suffer disappointing setbacks.

Website: https://www.sickeconomics.com/2021/03/05/mesoblast-limited-stock-2021/

Category: Contact NumberShow more

(MESO) Why Mesoblast Stock Is Plunging After Q4 Earnings

2 hours ago Benzinga.com Get All

Why It Matters: Mesoblast posted revenue of $7.5 million, down 77% Y/Y. It posted a wider net loss of $98.8 million compared to $77.9 million. Cash on hand was $136.9 million, but Mesoblast

Website: https://www.benzinga.com/general/biotech/21/08/22742700/why-mesoblast-stock-is-plunging-after-q4-earnings-report

Category: Contact NumberShow more

Mesoblast Limited (MESO) Stock Price, News, Quote, Chart

5 hours ago Stockstelegraph.com Get All

Mesoblast Limited (MESO) Mesoblast Limited (MESO) stock rallied over 2.13% intraday to trade at $6.23 share on NASDAQ. The stock opened with a gain of % at $6.19 and touched an intraday high of $6.33, rising 3.77% against the last close of $6.10. The stock went to a low of $6.14 during the session.

Website: https://stockstelegraph.com/quote/?stock=MESO

Category: Contact NumberShow more

MGM Growth Properties Investor Center Investor Contact

1 hours ago Mgmgrowthproperties.com Get All

Investor Relations. [email protected] Accountants. Deloitte & Touche, LLP 3883 Howard Hughes Parkway, Suite 400 Las Vegas, NV 89169-0924

Website: https://www.mgmgrowthproperties.com/investor-center/investor-contact/default.aspx

Category: Contact SupportShow more

Mesoblast COVID19 ARDS Phase III readout later this

4 hours ago Edisongroup.com Get All

Mesoblast has initiated a 300-patient randomized, controlled Phase III trial of remestemcel-L (Ryoncil for the acute graft versus host disease (aGvHD) indication) in COVID-19 patients with moderate/severe acute respiratory distress syndrome (ARDS) who are on ventilator support. The primary endpoint is all-cause mortality up to 30 days post randomization.

Website: https://www.edisongroup.com/publication/covid-19-ards-phase-iii-readout-later-this-year/27182/

Category: Contact NumberShow more

Mesoblast News Today (ASX:MSB) MarketBeat

7 hours ago Marketbeat.com Get All

msn.com - July 8 at 5:39 PM. Mesoblast (ASX:MSB) share price surges 5% in early trade today. fool.com.au - July 1 at 1:35 AM. The day’s big winners, including Mesoblast and WiseTech, plus more good economic news and borrowers taking more risk. msn.com - June 9 at 7:37 AM.

Website: https://www.marketbeat.com/stocks/ASX/MSB/news/

Category: Contact NumberShow more

MESO Mesoblast Ltd. ADR Company Profile & Executives WSJ

8 hours ago Wsj.com Get All

Company profile for Mesoblast Ltd. ADR including key executives, insider trading, ownership, revenue and average growth rates. View detailed MESO description & address.

Website: https://www.wsj.com/market-data/quotes/MESO/company-people

Category: Contact NumberShow more

Mesoblast Competitors and Alternatives 2021 (NASDAQ:MESO)

5 hours ago Marketbeat.com Get All

Mesoblast presently has a consensus target price of $14.3750, suggesting a potential upside of 94.52%. Translate Bio has a consensus target price of $26.2857, suggesting a potential downside of 29.40%. Given Mesoblast's higher probable upside, equities analysts plainly believe Mesoblast is more favorable than Translate Bio. Profitability

Website: https://www.marketbeat.com/stocks/NASDAQ/MESO/competitors-and-alternatives/

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Who is the founder of the company mesoblast?

Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

Where can i find the mesoblast biopharmcatalyst website?

Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com, LinkedIn: Mesoblast Limited and Twitter: @Mesoblast

Do you need to talk to your doctor about mesoblast?

Mesoblast is unable to advise people about their medical condition or appropriate treatment. People who are interested in enrolling in clinical trials should discuss it with their own doctor, who can then refer them to the clinical trial doctors, if appropriate. Links to general information about our ongoing clinical trials are provided below:

What are the phase 3 products of home mesoblast?

The Company’s portfolio of Phase 3 product candidates are: The Company also has a promising emerging pipeline and next generation technologies.

Brand New Updated

Popular Brands

Merck
Man
Maaden
Mcx
Midea
Metro
Mapfre